Efficacy and safety of deferasirox (Exjade®) in patients with β-thalassemia major treated for up to 5 years
暂无分享,去创建一个
S. Perrotta | M. Cappellini | A. Piga | Y. Kilinç | D. Canatan | A. Kattamis | J. Porter | Y. Aydinok | L. Griffel | G. Drelichman | C. Magnano | M. Capra | L. Ağaoğlu | Joan Clark | D. Lagrone